Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC3153 | TNBC | Basal A | Etoposide | TOP2 | TOP | 0.00427 | uM | 7467.074 | 0.9756 | 0.9607 | 1.2457 | |
HCC3153 | TNBC | Basal A | Etoposide | TOP2 | TOP | 0.0213 | uM | 7467.074 | 1.0153 | 1.0245 | 1.2457 | |
HCC3153 | TNBC | Basal A | Etoposide | TOP2 | TOP | 0.107 | uM | 7467.074 | 0.9674 | 0.9475 | 1.2457 | |
HCC3153 | TNBC | Basal A | Etoposide | TOP2 | TOP | 0.533 | uM | 7467.074 | 0.8363 | 0.7327 | 1.2457 | |
HCC3153 | TNBC | Basal A | Etoposide | TOP2 | TOP | 2.67 | uM | 7467.074 | 0.6415 | 0.4004 | 1.2457 | |
HCC3153 | TNBC | Basal A | Etoposide | TOP2 | TOP | 13.3 | uM | 7467.074 | 0.1734 | -0.5101 | 1.2457 | |
HCC3153 | TNBC | Basal A | Etoposide | TOP2 | TOP | 66.7 | uM | 7467.074 | 0.0549 | -0.8054 | 1.2457 | |
HCC3153 | TNBC | Basal A | Etoposide | TOP2 | TOP | 333 | uM | 7467.074 | 0.0496 | -0.8207 | 1.2457 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 0.000853 | uM | 7468.074 | 0.9969 | 0.9959 | 1.5027 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 0.00427 | uM | 7468.074 | 0.9642 | 0.9521 | 1.5027 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 0.0213 | uM | 7468.074 | 0.9505 | 0.9336 | 1.5027 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 0.107 | uM | 7468.074 | 0.8645 | 0.8153 | 1.5027 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 0.533 | uM | 7468.074 | 0.4336 | 0.1469 | 1.5027 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 2.67 | uM | 7468.074 | 0.1087 | -0.5432 | 1.5027 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 13.3 | uM | 7468.074 | 0.0340 | -0.7893 | 1.5027 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 66.7 | uM | 7468.074 | 0.0331 | -0.7930 | 1.5027 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 333 | uM | 7468.074 | 0.0273 | -0.8181 | 1.5027 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 0.000853 | uM | 7469.074 | 1.0516 | 1.0513 | 1.9843 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 0.00427 | uM | 7469.074 | 1.0472 | 1.0471 | 1.9843 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 0.0213 | uM | 7469.074 | 0.9800 | 0.9797 | 1.9843 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 0.107 | uM | 7469.074 | 0.9175 | 0.9150 | 1.9843 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 0.533 | uM | 7469.074 | 0.4390 | 0.3208 | 1.9843 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 2.67 | uM | 7469.074 | 0.1138 | -0.3310 | 1.9843 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 13.3 | uM | 7469.074 | 0.0523 | -0.5478 | 1.9843 | |
HCC38 | TNBC | Basal B | Etoposide | TOP2 | TOP | 66.7 | uM | 7469.074 | 0.0500 | -0.5580 | 1.9843 |